Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003800 · ClinicalTrials.gov registry record · NA
Diagnostic Study of Patients With Stage I Testicular Cancer
A NA study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT00003800 is a NA study that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 76 participants.
The verdict
NCT00003800, a NA study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures may improve a doctor's ability to predict the recurrence of testicular cancer. PURPOSE: Diagnostic trial to detect the risk of recurrent disease in patients who have stage I testicular cancer and who have undergone orchiectomy within the previous 12 weeks.
Interventions
- OTHER laboratory biomarker analysis
- OTHER immunohistochemistry staining method
- PROCEDURE radionuclide imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 1999-11-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003800
The ClinicalTrials.gov registry entry for NCT00003800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00003800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003800 about?
NCT00003800 is a clinical study titled "Diagnostic Study of Patients With Stage I Testicular Cancer". RATIONALE: Diagnostic procedures may improve a doctor's ability to predict the recurrence of testicular cancer. PURPOSE: Diagnostic trial to detect the risk of recurrent disease in patients who have stage I testicular cancer and who have undergone orchiectomy within the previous 12 weeks.
What is the current status of trial NCT00003800?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 1999-11-16.
What interventions are being tested in trial NCT00003800?
The interventions under investigation include: laboratory biomarker analysis (OTHER), immunohistochemistry staining method (OTHER), radionuclide imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00003800?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.